Peramivir Market Scope and Size by 2031
The Peramivir Market is expected to register a CAGR of 5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Peramivir Market report is segmented by type into Solution and Solid. The application segment includes Influenza A Treatment and Influenza B Treatment. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Peramivir Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Peramivir Market Segmentation
Type- Solution
- Solid
- Influenza A Treatment
- Influenza B Treatment
Strategic Insights
Peramivir Market Growth Drivers- Growing Trend of Influenza Seasonality: It has fairly established the effectiveness of this drug in curing influenza as well as more severe ones. As such, the number of the geriatric population susceptible to influenza resulting in serious infections will create more market demand.
- Advancements in Healthcare Infrastructure and Awareness: Improvements in healthcare infrastructures and increasing awareness towards preventing and treating influenza have created momentum in the market.
- Efficacy in Treating Severe Influenza Cases:
Peramivir's ability to provide rapid relief through intravenous administration makes it a preferred option for hospitalized patients with severe influenza. Research on peramivir is under way for it to explore further antiviral use in general; therefore, the market of this medicine is most probably to grow constantly in the short-term period.
- Pandemic Preparedness: As the world is gradually aware of the potential for pandemics in the future, it is expected that more antiviral medications with higher efficacy than peramivir will be needed.
- R&D Advancements in Peramivir: More R&D work is going into peramivir in formulating and delivery technology for better efficacy and better patient compliance.
- Prophylactic Use of Peramivir: More scope of market growth can also be realized by considering peramivir as a prophylactic agent.
- Rising Incidence of Influenza Among Vulnerable Populations: The incidence of influenza is rapidly rising among the elderly and immunocompromised patients, and, thus, there is significant demand for effective antiviral treatments.
- Prophylactic Use in High-Risk Settings: Another area with a huge market potential relates to the prophylactic use of peramivir, especially in high-risk settings like hospitals and nursing homes.
- Research and Development in Formulation and Combination Therapies: More research and development work into enhancing the formulation, delivery, and combination therapies with other antiviral drugs could open up more applications for peramivir.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Peramivir Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Peramivir Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Peramivir Market is expected to grow at a CAGR of 5% between 2023-2031
Several factors drive the peramivir market. Primarily, the increasing number of influenza cases, more significantly during seasonal outbreaks, forms a major driver. Since the drug is effective for severe cases of influenza, its importance in treatment cannot be denied. Moreover, with the increase in geriatric population, which tends to be more vulnerable to such severe infections, drives demand in the market even more. In addition, the development of healthcare infrastructure and the awareness of prevention and treatment of influenza are factors that are driving the market forward. As research continues to explore the potential of peramivir in broader antiviral applications, the market is expected to see continued growth in the years ahead.
The future of the peramivir market is bright, with several emerging trends. One of the most important trends is the increasing focus on pandemic preparedness. As the world develops an increased awareness of the possibility for future pandemics, more demand for effective antiviral drugs such as peramivir will certainly be seen. Furthermore, present research and development is continuing to work on formulating and delivering peramivir in a better fashion, which may bring a better response and adherence rate in patients. In addition, the prophylactic potential of peramivir is also under scrutiny, which will create some more opportunities for growth. However, long-term trend of the peramivir market may be affected by challenges such as the emergence of drug-resistant influenza strains and development of new antiviral agents.
The leading players of the market are: Green Cross Pharma, Shionogi Co., Neopharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals, Hunan Nucien Pharmaceutical Co., Ltd., SCOLR Pharma, BioCryst Pharmaceuticals, Inc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peramivir Market - By Type
1.3.2 Peramivir Market - By Application
1.3.3 Peramivir Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PERAMIVIR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PERAMIVIR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PERAMIVIR MARKET - GLOBAL MARKET ANALYSIS
6.1. PERAMIVIR - GLOBAL MARKET OVERVIEW
6.2. PERAMIVIR - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PERAMIVIR MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SOLUTION
7.3.1. Overview
7.3.2. Solution Market Forecast and Analysis
7.4. SOLID
7.4.1. Overview
7.4.2. Solid Market Forecast and Analysis
8. PERAMIVIR MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. INFLUENZA A TREATMENT
8.3.1. Overview
8.3.2. Influenza A Treatment Market Forecast and Analysis
8.4. INFLUENZA B TREATMENT
8.4.1. Overview
8.4.2. Influenza B Treatment Market Forecast and Analysis
9. PERAMIVIR MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Peramivir Market Overview
9.1.2 North America Peramivir Market Forecasts and Analysis
9.1.3 North America Peramivir Market Forecasts and Analysis - By Type
9.1.4 North America Peramivir Market Forecasts and Analysis - By Application
9.1.5 North America Peramivir Market Forecasts and Analysis - By Countries
9.1.5.1 United States Peramivir Market
9.1.5.1.1 United States Peramivir Market by Type
9.1.5.1.2 United States Peramivir Market by Application
9.1.5.2 Canada Peramivir Market
9.1.5.2.1 Canada Peramivir Market by Type
9.1.5.2.2 Canada Peramivir Market by Application
9.1.5.3 Mexico Peramivir Market
9.1.5.3.1 Mexico Peramivir Market by Type
9.1.5.3.2 Mexico Peramivir Market by Application
9.2. EUROPE
9.2.1 Europe Peramivir Market Overview
9.2.2 Europe Peramivir Market Forecasts and Analysis
9.2.3 Europe Peramivir Market Forecasts and Analysis - By Type
9.2.4 Europe Peramivir Market Forecasts and Analysis - By Application
9.2.5 Europe Peramivir Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Peramivir Market
9.2.5.1.1 Germany Peramivir Market by Type
9.2.5.1.2 Germany Peramivir Market by Application
9.2.5.2 France Peramivir Market
9.2.5.2.1 France Peramivir Market by Type
9.2.5.2.2 France Peramivir Market by Application
9.2.5.3 Italy Peramivir Market
9.2.5.3.1 Italy Peramivir Market by Type
9.2.5.3.2 Italy Peramivir Market by Application
9.2.5.4 Spain Peramivir Market
9.2.5.4.1 Spain Peramivir Market by Type
9.2.5.4.2 Spain Peramivir Market by Application
9.2.5.5 United Kingdom Peramivir Market
9.2.5.5.1 United Kingdom Peramivir Market by Type
9.2.5.5.2 United Kingdom Peramivir Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Peramivir Market Overview
9.3.2 Asia-Pacific Peramivir Market Forecasts and Analysis
9.3.3 Asia-Pacific Peramivir Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Peramivir Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Peramivir Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Peramivir Market
9.3.5.1.1 Australia Peramivir Market by Type
9.3.5.1.2 Australia Peramivir Market by Application
9.3.5.2 China Peramivir Market
9.3.5.2.1 China Peramivir Market by Type
9.3.5.2.2 China Peramivir Market by Application
9.3.5.3 India Peramivir Market
9.3.5.3.1 India Peramivir Market by Type
9.3.5.3.2 India Peramivir Market by Application
9.3.5.4 Japan Peramivir Market
9.3.5.4.1 Japan Peramivir Market by Type
9.3.5.4.2 Japan Peramivir Market by Application
9.3.5.5 South Korea Peramivir Market
9.3.5.5.1 South Korea Peramivir Market by Type
9.3.5.5.2 South Korea Peramivir Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Peramivir Market Overview
9.4.2 Middle East and Africa Peramivir Market Forecasts and Analysis
9.4.3 Middle East and Africa Peramivir Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Peramivir Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Peramivir Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Peramivir Market
9.4.5.1.1 South Africa Peramivir Market by Type
9.4.5.1.2 South Africa Peramivir Market by Application
9.4.5.2 Saudi Arabia Peramivir Market
9.4.5.2.1 Saudi Arabia Peramivir Market by Type
9.4.5.2.2 Saudi Arabia Peramivir Market by Application
9.4.5.3 U.A.E Peramivir Market
9.4.5.3.1 U.A.E Peramivir Market by Type
9.4.5.3.2 U.A.E Peramivir Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Peramivir Market Overview
9.5.2 South and Central America Peramivir Market Forecasts and Analysis
9.5.3 South and Central America Peramivir Market Forecasts and Analysis - By Type
9.5.4 South and Central America Peramivir Market Forecasts and Analysis - By Application
9.5.5 South and Central America Peramivir Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Peramivir Market
9.5.5.1.1 Brazil Peramivir Market by Type
9.5.5.1.2 Brazil Peramivir Market by Application
9.5.5.2 Argentina Peramivir Market
9.5.5.2.1 Argentina Peramivir Market by Type
9.5.5.2.2 Argentina Peramivir Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PERAMIVIR MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PERAMIVIR MARKET, KEY COMPANY PROFILES
12.1. GREEN CROSS PHARMA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SHIONOGI CO.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NEOPHARM
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MOKSHA8 PHARMA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NT PHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. HIKMA PHARMACEUTICALS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HUNAN NUCIEN PHARMACEUTICAL CO., LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SCOLR PHARMA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIOCRYST PHARMACEUTICALS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Green Cross Pharma
2. Shionogi Co.
3. Neopharm
4. Moksha8 Pharma
5. NT Pharma
6. Merck
7. Hikma Pharmaceuticals
8. Hunan Nucien Pharmaceutical Co., Ltd.
9. SCOLR Pharma
10. BioCryst Pharmaceuticals, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For